The metabolic syndrome is a complex condition characterized by dyslipidaemia, high blood pressure, impaired glucose tolerance and abdominal fat accumulation. Subjects with the metabolic syndrome are at high risk of atherosclerosis and coronary heart disease. A comprehensive approach is required for patients suffering this cluster of clinical manifestations. Indeed, subjects with the metabolic syndrome could benefit from life-style modifications, particularly through exercise and diet. In this article, the evidence regarding the role of diet, in particular the role of food patterns based on the Mediterranean-style diet, in preventing and treating the metabolic syndrome are reviewed. Keywords Mediterranean diet · Metabolic syndrome · Diet IntroductionThere are many definitions of the metabolic syndrome, being still a matter of debate ( Table 1). The metabolic syndrome has its origins in 1923 when Kylin described a syndrome involving hypertension, hyperglycaemia and hyperuricaemia [1]. Later, Vague in 1947 linked abdominal obesity to metabolic abnormalities (i.e. diabetes, atherosclerosis, gout and calculi) [2]. In 1967, Avogaro et al. described six obese patients with diabetes, hypercholesterolaemia, and marked hypertriglyceridaemia, all of whom improved on a hypocaloric and low-carbohydrate diet [3]. In the 1970s, Phillips suggested associations of aging, obesity and sex hormone-associated clinical manifestations with heart disease [4,5]. In the late 1980s, Reaven proposed insulin resistance as the critical factor and coined the name syndrome-X [6].However, the most extensive definitions were established by the World Health Organization (WHO) and the National Cholesterol Education Program Adult Treatment Panel III (NCEP ATPIII). In these definitions an enhanced cholesterol/high-density lipoprotein (HDL) ratio is considered a factor in the metabolic syndrome as well as elevated low-density lipoprotein cholesterol, atherogenic dyslipidaemia, insulin resistance, hypertension, abdominal obesity and elevated levels of several inflammatory markers [7,8]. In 2005 the International Diabetes Federation (IDF) emphasized abdominal obesity as the initiating factor in metabolic syndrome [9]. Although the definition of the metabolic syndrome makes little difference to prognosis [10,11], the IDF definition appears to be the most useful in clinical practice and considers different ethnic-related definitions of obesity.Each of the abnormalities promotes atherosclerosis independently, but the clustering of risk factors signifi- cantly reduces the quality of life [12] and increases the risk of cardiovascular morbidity and mortality. Indeed, the metabolic syndrome has been associated with an approximate twofold increased risk of cardiovascular morbidity and mortality in a European population [13]. The risk of cardiovascular morbidity and mortality is significantly higher among people with metabolic syndrome [14] even in the absence of baseline health conditions such as cardiovascular disease (CVD) and diabetes [15].The INTER...
The metabolic syndrome is a complex condition characterized by dyslipidaemia, high blood pressure, impaired glucose tolerance and abdominal fat accumulation. Subjects with the metabolic syndrome are at high risk of atherosclerosis and coronary heart disease. A comprehensive approach is required for patients suffering this cluster of clinical manifestations. Indeed, subjects with the metabolic syndrome could benefit from life-style modifications, particularly through exercise and diet. In this article, the evidence regarding the role of diet, in particular the role of food patterns based on the Mediterranean-style diet, in preventing and treating the metabolic syndrome are reviewed.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
customersupport@researchsolutions.com
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.